Ibuprofeno Stadapharm

Ibuprofen, the active ingredient in Ibuprofeno Stadapharm, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It treats mild to moderate pain, fever, and inflammatory conditions in adults and children.

GNH USA supplies Ibuprofeno Stadapharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is a non‑selective NSAID that reduces inflammation and pain by inhibiting prostaglandin synthesis.

- Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal aches, and postoperative discomfort. - Fever: lowers elevated body temperature in febrile states. - Inflammatory arthritis: eases joint pain and swelling in osteoarthritis and rheumatoid arthritis.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Mild skin rash or itching. - Elevated liver enzymes (asymptomatic).

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Severe allergic reactions such as anaphylaxis. - Renal impairment or acute kidney injury. - Hepatotoxicity with jaundice. - Cardiovascular events including myocardial infarction or stroke. - Blood dyscrasias such as thrombocytopenia.

Before initiating therapy, consider the following precautions: - Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: avoid use in severe kidney disease without supervision. - Avoid in known hypersensitivity to ibuprofen or other NSAIDs. - Use the lowest effective dose: limit duration of therapy to the shortest necessary period. - Consider cardiovascular risk: exercise caution in patients with established heart disease. - Store at room temperature: keep in the original container, protect from moisture and heat.

Ibuprofen may interact with several medicines; review the following categories:

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - Lithium: ibuprofen can raise serum lithium concentrations. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible decline in renal function. - Diuretics: risk of renal impairment when combined. - Corticosteroids: increased ulcer risk. - Cyclosporine: enhanced nephrotoxicity. - Bismuth subsalicylate: additive antiplatelet effect.